(Q36075209)

12 August 2017

1 reference

title

How pharmacogenomics will play a role in the management of asthma (English)

1 reference

12 August 2017

1 reference

1 reference

Michael E Wechsler

1

1 reference

12 August 2017

Elliot Israel

series ordinal

2

1 reference

12 August 2017

language of work or name

English

0 references

publication date

18 March 2005

1 reference

American Journal of Respiratory and Critical Care Medicine

12 August 2017

published in

1 reference

12 August 2017

volume

172

1 reference

12 August 2017

issue

1

1 reference

12 August 2017

page(s)

12-18

1 reference

Is overall asthma control being achieved? A hypothesis-generating study

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1635OE

Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1635OE

Significant variability in response to inhaled corticosteroids for persistent asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1635OE

Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma. A randomized, controlled trial. Montelukast/Beclomethasone Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1635OE

Osteoporosis in the corticosteroid-treated patient with asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1635OE

Risk factors associated with glucocorticoid-induced adverse effects in children with severe asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1635OE

Association of inhaled corticosteroid use with cataract extraction in elderly patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1635OE

Use of inhaled corticosteroids and the risk of cataracts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1635OE

Inhaled and nasal glucocorticoids and the risks of ocular hypertension or open-angle glaucoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1635OE

Serevent nationwide surveillance study: comparison of salmeterol with salbutamol in asthmatic patients who require regular bronchodilator treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1635OE

Heterogeneity of therapeutic responses in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1635OE

Using single nucleotide polymorphisms as a means to understanding the pathophysiology of asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1635OE

Single nucleotide polymorphisms as tools in human genetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1635OE

Single nucleotide polymorphisms and the future of genetic epidemiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1635OE

Association of the ADAM33 gene with asthma and bronchial hyperresponsiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1635OE

Pharmacogenetic differences in response to albuterol between Puerto Ricans and Mexicans with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1635OE

Influence of cigarette smoking on inhaled corticosteroid treatment in mild asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1635OE

Beta 2-adrenergic receptor polymorphisms and haplotypes are associated with airways hyperresponsiveness among nonsmoking men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1635OE

Amino-terminal polymorphisms of the human beta 2-adrenergic receptor impart distinct agonist-promoted regulatory properties.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1635OE

Complex promoter and coding region beta 2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1635OE

Influence of beta 2-adrenergic receptor genotypes on signal transduction in human airway smooth muscle cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1635OE

Association between genetic polymorphisms of the beta2-adrenoceptor and response to albuterol in children with and without a history of wheezing

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1635OE

Impact of genetic polymorphisms of the beta2-adrenergic receptor on albuterol bronchodilator pharmacodynamics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1635OE

The effect of polymorphisms of the beta(2)-adrenergic receptor on the response to regular use of albuterol in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1635OE

Asthma exacerbations during long term beta agonist use: influence of beta(2) adrenoceptor polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1635OE

Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebo-controlled cross-over trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1635OE

Naturally occurring mutations in the human 5-lipoxygenase gene promoter that modify transcription factor binding and reporter gene transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1635OE

Egr-1 and Sp1 interact functionally with the 5-lipoxygenase promoter and its naturally occurring mutants

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1635OE

Variant LTC(4) synthase allele modifies cysteinyl leukotriene synthesis in eosinophils and predicts clinical response to zafirlukast

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1635OE

Leukotriene C4 synthase polymorphisms and responsiveness to leukotriene antagonists in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1635OE

Corticosteroid pharmacogenetics: association of sequence variants in CRHR1 with improved lung function in asthmatics treated with inhaled corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1635OE

Corticotropin-releasing hormone deficiency increases allergen-induced airway inflammation in a mouse model of asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1635OE

TBX21: a functional variant predicts improvement in asthma with the use of inhaled corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1635OE

Family-based association analysis of β2-adrenergic receptor polymorphisms in the childhood asthma management program

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1635OE

10.1164/RCCM.200412-1635OE

21 January 2018

Identifiers

DOI

1 reference

release_x4rz4sxstjebpcge2jmvt4bojy

12 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/x4rz4sxstjebpcge2jmvt4bojy

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference